Abstract
Since the discovery that deletion of the NF-κB subunits p50 and p52 causes osteopetrosis in mice, there has been considerable interest in the role of NF-κB signaling in bone. NF-κB controls the differentiation or activity of the major skeletal cell types- osteoclasts, osteoblasts, osteocytes and chondrocytes. However, with five NF-κB subunits and two distinct activation pathways, not all NF-κB signals lead to the same physiologic responses. In this review, we will describe the roles of various NF-κB proteins in basal bone homeostasis and disease states, and explore how NF-κB inhibition might be utilized therapeutically.
Original language | English |
---|---|
Pages (from-to) | 169-182 |
Number of pages | 14 |
Journal | Cell Research |
Volume | 21 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2011 |
Keywords
- Osteoclast
- arthritis
- chondrocyte
- osteoblast
- osteoporosis